STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
28.21
+0.82 (2.99%)
Aug 13, 2025, 4:00 PM - Market closed
STAAR Surgical Company Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for STAAR Surgical Company stock ranges from a low of $16 to a high of $28. The average analyst price target of $22.5 forecasts a -20.24% decrease in the stock price over the next year.
Price Target: $22.50 (-20.24%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for STAAR Surgical Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 6 | 8 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy → Hold Downgrades $20 → $28 | Strong Buy → Hold | Downgrades | $20 → $28 | -0.74% | Aug 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $20 → $28 | Hold | Maintains | $20 → $28 | -0.74% | Aug 6, 2025 |
| Sidoti & Co. | Sidoti & Co. | Strong Buy → Hold Downgrades $27 → $28 | Strong Buy → Hold | Downgrades | $27 → $28 | -0.74% | Aug 5, 2025 |
| Mizuho | Mizuho | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | -36.19% | Jul 16, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $20 | Hold | Maintains | $20 | -29.10% | May 27, 2025 |
Financial Forecast
Revenue This Year
259.28M
from 313.90M
Decreased by -17.40%
Revenue Next Year
327.01M
from 259.28M
Increased by 26.12%
EPS This Year
-1.76
from -0.41
EPS Next Year
-0.15
from -1.76
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 286.4M | 411.2M | 441.6M | ||
| Avg | 259.3M | 327.0M | 351.8M | ||
| Low | 237.3M | 261.1M | 291.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -8.7% | 58.6% | 35.1% | ||
| Avg | -17.4% | 26.1% | 7.6% | ||
| Low | -24.4% | 0.7% | -10.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.29 | 0.51 | 1.54 | ||
| Avg | -1.76 | -0.15 | 0.37 | ||
| Low | -2.08 | -0.66 | -0.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.